Cohort Study: Long-Acting Erythropoietin-Stimulating Agents Linked to Increased Mortality Among Patients Undergoing Hemodialysis
21 May, 2019 | 19:20h | UTCStudy: Long-Acting ESA Users Might Have Worse Survival – Renal & Urology News (free)
Original Article: Types of Erythropoietin-Stimulating Agents and Mortality among Patients Undergoing Hemodialysis – Journal of the American Society of Nephrology (link to abstract – $ for full-text)